KCNMA1 and neoplasm: To avoid large variation in tumor sizes due to heterogeneity of breast cancer, we selected pairs of tumors (one as a control – injected PBS only, the other treated – injected drug in PBS) that had similar tumor sizes, and performed ultrasound imaging for four weeks to monitor effect of BK channel opener during the growth of tumors.